Yıl: 2019 Cilt: 47 Sayı: 3 Sayfa Aralığı: 177 - 184 Metin Dili: İngilizce DOI: 10.5543/tkda.2018.45213 İndeks Tarihi: 03-06-2020

Is prolactin serum level and coronary artery atherosclerosis correlated in postmenopausal women? A cross-sectional study

Öz:
Objective: Prolactin is correlated with some conditions thatpredispose individuals to atherosclerosis. Prolactin receptorshave been found in atherosclerotic plaques. However, a correlationbetween the serum prolactin level and the extensionand severity of coronary artery atherosclerosis has yet to bestudied. This study was an examination of that relationship.Methods: In total, 414 postmenopausal women with normalserum prolactin levels who were candidates for selectivecoronary angiography were enrolled. The patients’ lipidprofile and levels of serum prolactin, thyroid-stimulating hormone,C-reactive protein, urea, creatinine, and fasting bloodsugar were measured. The Gensini score for each patientwas calculated. The study population was divided into 3groups according to the tertile of the serum prolactin level.Results: There was no statistically significant differencein the Gensini score results between the 3 groups in theunivariate analysis (p=0.075). The multivariable analysisshowed that the serum prolactin level was not an independentdeterminant of the Gensini score (p=0.430), whereasage, hypertension, diabetes, and dyslipidemia were independentdeterminants of the Gensini score.Conclusion: There was no statistically significant correlationbetween the serum prolactin level and coronary arteryatherosclerosis expressed as the Gensini score in this sampleof postmenopausal women.
Anahtar Kelime:

Postmenopozal kadınlarda serum prolaktin düzeyi ve koroner arter aterosklerozu arasında bir korelasyon var mı? Bir kesitsel çalışma

Öz:
Amaç: Prolaktin düzeyi, ateroskleroza eğilimi artıran çeşitli durumlarla ilişkilidir. Aterom plaklarında prolaktin reseptörleri bulunmuştur. Ancak serum prolaktin düzeyiyle koroner arter aterosklerozunun yaygınlık ve ciddiyeti arasında korelasyon henüz çalışılmamıştır. Bu çalışma bu ilişkiyi incelemektedir. Yöntemler: Selektif koroner anjiyografi adayı olan, serum prolaktin düzeyleri normal 414 postmenopozal kadın çalışmaya alındı. Hastaların lipit profilleri, serum prolaktin, tiroit uyarıcı hormon, C-reaktif protein, üre, kreatinin ve açlık kan şekeri düzeyleri ölçüldü. Her bir hastanın Gensini skoru hesaplandı. Çalışma popülasyonu serum prolaktin düzeyinin üçte birlik dilimlerine göre 3 gruba ayrıldı. Bulgular: Tek değişkenli analizde 3 grubun Gensini skorları arasında istatistiksel açıdan anlamlı herhangi bir farklılık yoktu (p=0.075). Çok değişkenli analizde, serum prolaktin düzeyinin Gensini skoru için bağımsız bir belirleyici olmadığı (p=0.430), buna karşılık yaş, hipertansiyon ve diyabetin bağımsız belirleyiciler olduğu saptandı. Sonuç: Bu çalışmada, postmenopozal kadınlarda serum prolaktin düzeyiyle Gensini skoruyla ifade edilen koroner arter aterosklerozu arasında istatistiksel açıdan anlamlı bir korelasyon bulunmadı.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Bernard V, Young J, Chanson P, Binart N. New insights in prolactin: pathological implications. Nat Rev Endocrinol 2015;11:265–75.
  • 2. Friedrich N, Schneider HJ, Spielhagen C, Markus MR, Haring R, Grabe HJ, et al. The association of serum prolactin concentration with inflammatory biomarkers - cross-sectional findings from the population-based Study of Health in Pomerania. Clin Endocrinol (Oxf) 2011;75:561–6.
  • 3. Wagner R, Heni M, Linder K, Ketterer C, Peter A, Böhm A, et al. Age-dependent association of serum prolactin with glycaemia and insulin sensitivity in humans. Acta Diabetol 2014;51:71–8.
  • 4. Berinder K, Nyström T, Höybye C, Hall K, Hulting AL. Insulin sensitivity and lipid profile in prolactinoma patients before and after normalization of prolactin by dopamine agonist therapy. Pituitary 2011;14:199–207.
  • 5. Therkelsen KE, Abraham TM, Pedley A, Massaro JM, Sutherland P, Hoffmann U, et al. Association Between Prolactin and Incidence of Cardiovascular Risk Factors in the Framingham Heart Study. J Am Heart Assoc 2016;5. pii: e002640.
  • 6. Zhang L, Curhan GC, Forman JP. Plasma prolactin level and risk of incident hypertension in postmenopausal women. J Hypertens 2010;28:1400–5.
  • 7. Roelfsema F, Pijl H, Keenan DM, Veldhuis JD. Prolactin secretion in healthy adults is determined by gender, age and body mass index. PLoS One 2012;7:e31305.
  • 8. Georgiopoulos G, Lambrinoudaki I, Athanasouli F, Armeni E, Koliviras A, Augoulea A, et al. Prolactin as a predictor of endothelial dysfunction and arterial stiffness progression in menopause. J Hum Hypertens 2017;31:520–4.
  • 9. Urban A, Masopust J, Malý R, Hosák L, Kalnická D. Prolactin as a factor for increased platelet aggregation. Neuro Endocrinol Lett 2007;28:518–23.
  • 10. Erem C, Kocak M, Nuhoglu I, Yılmaz M, Ucuncu O. Blood coagulation, fibrinolysis and lipid profile in patients with prolactinoma. Clin Endocrinol (Oxf) 2010;73:502–7.
  • 11. Sauro MD, Zorn NE. Prolactin induces proliferation of vascular smooth muscle cells through a protein kinase C-dependent mechanism. J Cell Physiol 1991;148:133–8.
  • 12. Reuwer AQ, van Eijk M, Houttuijn-Bloemendaal FM, van der Loos CM, Claessen N, Teeling P, et al. The prolactin receptor is expressed in macrophages within human carotid atherosclerotic plaques: a role for prolactin in atherogenesis? J Endocrinol 2011;208:107–17.
  • 13. Reuwer AQ, Nowak-Sliwinska P, Mans LA, van der Loos CM, von der Thüsen JH, Twickler MT, et al. Functional consequences of prolactin signalling in endothelial cells: a potential link with angiogenesis in pathophysiology? J Cell Mol Med 2012;16:2035–48.
  • 14. Montes de Oca P, Macotela Y, Nava G, López-Barrera F, de la Escalera GM, Clapp C. Prolactin stimulates integrin-mediated adhesion of circulating mononuclear cells to endothelial cells. Lab Invest 2005;85:633–42.
  • 15. Arslan MS, Topaloglu O, Sahin M, Tutal E, Gungunes A, Cakir E, et al. Preclinical atherosclerosis in patients with prolactinoma. Endocr Pract 2014;20:447–51.
  • 16. Jiang XB, Li CL, He DS, Mao ZG, Liu DH, Fan X, et al. Increased carotid intima media thickness is associated with prolactin levels in subjects with untreated prolactinoma: a pilot study. Pituitary 2014;17:232–9.
  • 17. Raaz D, Wallaschofski H, Stumpf C, Yilmaz A, Cicha I, Klinghammer L, et al. Increased prolactin in acute coronary syndromes as putative Co-activator of ADP-stimulated P-selectin expression. Horm Metab Res 2006;38:767–72.
  • 18. Kassi E, Spilioti E, Nasiri-Ansari N, Adamopoulos C, Moutsatsou P, Papapanagiotou A, et al. Vascular Inflammation and Atherosclerosis: The Role of Estrogen Receptors. Curr Med Chem 2015;22:2651–65.
  • 19. Haring R, Friedrich N, Völzke H, Vasan RS, Felix SB, Dörr M, et al. Positive association of serum prolactin concentrations with all-cause and cardiovascular mortality. Eur Heart J 2014;35:1215–21.
  • 20. Reuwer AQ, Twickler MT, Hutten BA, Molema FW, Wareham NJ, Dallinga-Thie GM, et al. Prolactin levels and the risk of future coronary artery disease in apparently healthy men and women. Circ Cardiovasc Genet 2009;2:389–95.
  • 21. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002;106:3143–421.
  • 22. Ishizuka B, Quigley ME, Yen SS. Pituitary hormone release in response to food ingestion: evidence for neuroendocrine signals from gut to brain. J Clin Endocrinol Metab 1983;57:1111–6.
  • 23. Gensini GG. A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol 1983;51:606.
  • 24. Georgiopoulos GA, Stamatelopoulos KS, Lambrinoudaki I, Lykka M, Kyrkou K, Rizos D, et al. Prolactin and preclinical atherosclerosis in menopausal women with cardiovascular risk factors. Hypertension 2009;54:98–105.
  • 25. Carrero JJ, Kyriazis J, Sonmez A, Tzanakis I, Qureshi AR, Stenvinkel P, et al. Prolactin levels, endothelial dysfunction, and the risk of cardiovascular events and mortality in patients with CKD. Clin J Am Soc Nephrol 2012;7:207–15.
  • 26. Yihua L, Yun J, Dongshen Z. Coronary Artery Disease in Premenopausal and Postmenopausal Women. Int Heart J 2017;58:174–9.
  • 27. Xu R, Cheng XC, Zhang Y, Lai HM, Yang HN. Association of Severity of Coronary Lesions with Bone Mineral Density in Postmenopausal Women. Arq Bras Cardiol 2018;110:211–6.
APA AMİRZADEGAN A, SALIMI E, Hosseinsabet A (2019). Is prolactin serum level and coronary artery atherosclerosis correlated in postmenopausal women? A cross-sectional study. , 177 - 184. 10.5543/tkda.2018.45213
Chicago AMİRZADEGAN Alireza,SALIMI Elnaz,Hosseinsabet Ali Is prolactin serum level and coronary artery atherosclerosis correlated in postmenopausal women? A cross-sectional study. (2019): 177 - 184. 10.5543/tkda.2018.45213
MLA AMİRZADEGAN Alireza,SALIMI Elnaz,Hosseinsabet Ali Is prolactin serum level and coronary artery atherosclerosis correlated in postmenopausal women? A cross-sectional study. , 2019, ss.177 - 184. 10.5543/tkda.2018.45213
AMA AMİRZADEGAN A,SALIMI E,Hosseinsabet A Is prolactin serum level and coronary artery atherosclerosis correlated in postmenopausal women? A cross-sectional study. . 2019; 177 - 184. 10.5543/tkda.2018.45213
Vancouver AMİRZADEGAN A,SALIMI E,Hosseinsabet A Is prolactin serum level and coronary artery atherosclerosis correlated in postmenopausal women? A cross-sectional study. . 2019; 177 - 184. 10.5543/tkda.2018.45213
IEEE AMİRZADEGAN A,SALIMI E,Hosseinsabet A "Is prolactin serum level and coronary artery atherosclerosis correlated in postmenopausal women? A cross-sectional study." , ss.177 - 184, 2019. 10.5543/tkda.2018.45213
ISNAD AMİRZADEGAN, Alireza vd. "Is prolactin serum level and coronary artery atherosclerosis correlated in postmenopausal women? A cross-sectional study". (2019), 177-184. https://doi.org/10.5543/tkda.2018.45213
APA AMİRZADEGAN A, SALIMI E, Hosseinsabet A (2019). Is prolactin serum level and coronary artery atherosclerosis correlated in postmenopausal women? A cross-sectional study. Türk Kardiyoloji Derneği Arşivi, 47(3), 177 - 184. 10.5543/tkda.2018.45213
Chicago AMİRZADEGAN Alireza,SALIMI Elnaz,Hosseinsabet Ali Is prolactin serum level and coronary artery atherosclerosis correlated in postmenopausal women? A cross-sectional study. Türk Kardiyoloji Derneği Arşivi 47, no.3 (2019): 177 - 184. 10.5543/tkda.2018.45213
MLA AMİRZADEGAN Alireza,SALIMI Elnaz,Hosseinsabet Ali Is prolactin serum level and coronary artery atherosclerosis correlated in postmenopausal women? A cross-sectional study. Türk Kardiyoloji Derneği Arşivi, vol.47, no.3, 2019, ss.177 - 184. 10.5543/tkda.2018.45213
AMA AMİRZADEGAN A,SALIMI E,Hosseinsabet A Is prolactin serum level and coronary artery atherosclerosis correlated in postmenopausal women? A cross-sectional study. Türk Kardiyoloji Derneği Arşivi. 2019; 47(3): 177 - 184. 10.5543/tkda.2018.45213
Vancouver AMİRZADEGAN A,SALIMI E,Hosseinsabet A Is prolactin serum level and coronary artery atherosclerosis correlated in postmenopausal women? A cross-sectional study. Türk Kardiyoloji Derneği Arşivi. 2019; 47(3): 177 - 184. 10.5543/tkda.2018.45213
IEEE AMİRZADEGAN A,SALIMI E,Hosseinsabet A "Is prolactin serum level and coronary artery atherosclerosis correlated in postmenopausal women? A cross-sectional study." Türk Kardiyoloji Derneği Arşivi, 47, ss.177 - 184, 2019. 10.5543/tkda.2018.45213
ISNAD AMİRZADEGAN, Alireza vd. "Is prolactin serum level and coronary artery atherosclerosis correlated in postmenopausal women? A cross-sectional study". Türk Kardiyoloji Derneği Arşivi 47/3 (2019), 177-184. https://doi.org/10.5543/tkda.2018.45213